Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.
A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target.
The sphere-forming frequency of neuroblastoma cells is a measure of their proliferative capacity and could help guide treatment strategies for neuroblastoma.
Increased activity of the “fight or flight” nervous system contributes to obesity-associated hypertension and may be a good therapeutic target for the disease.
Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.
Children with Prader-Willi Syndrome who received growth hormone treatment had cognitive advantages compared to untreated patients.